These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 213743)

  • 1. Enkephalins and nigrostriatal function.
    Diamond BI; Borison RL
    Neurology; 1978 Nov; 28(11):1085-8. PubMed ID: 213743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain endorphins: possible role in reward and memory formation.
    Stein L; Belluzzi JD
    Fed Proc; 1979 Oct; 38(11):2468-72. PubMed ID: 39791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endorphins, enkephalins and their antagonists in clinical practice (review of the literature)].
    Oleĭnik VA; Khalangot ND
    Vrach Delo; 1985 May; (5):80-6. PubMed ID: 2990108
    [No Abstract]   [Full Text] [Related]  

  • 6. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats.
    Mendez JS; Finn BW
    J Neurosurg; 1975 Feb; 42(2):166-73. PubMed ID: 234524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiplicity of opiate receptors and enkephalin neuronal systems.
    Snyder SH
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):9-12. PubMed ID: 6282818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatonigral prodynorphin: a model system for understanding opioid peptide function.
    Thompson LA; Matsumoto RR; Hohmann AG; Walker JM
    Ann N Y Acad Sci; 1990; 579():192-203. PubMed ID: 2159742
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing nature of pain control. Clinical aspects of endorphins and enkephalins.
    Hirst M
    J Can Dent Assoc; 1985 Jul; 51(7):493-8. PubMed ID: 2862981
    [No Abstract]   [Full Text] [Related]  

  • 11. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus.
    Maneuf YP; Mitchell IJ; Crossman AR; Brotchie JM
    Exp Neurol; 1994 Jan; 125(1):65-71. PubMed ID: 8307125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosinergic and dopaminergic interaction in nigrostriatum in FeCl3-induced model of parkinsonism in rats.
    Mathur R; Gupta YK
    Methods Find Exp Clin Pharmacol; 1999; 21(6):435-9. PubMed ID: 10445237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opioids may mediate post-ictal behavioral depression in amygdaloid-kindled rats.
    Frenk H; Engel J; Ackermann RF; Shavit Y; Liebeskind JC
    Brain Res; 1979 May; 167(2):435-40. PubMed ID: 221069
    [No Abstract]   [Full Text] [Related]  

  • 14. Ontogenesis of enkephalinergic systems in rat brain: post-natal changes in enkephalin levels, receptors and degrading enzyme activities.
    Patey G; de la Baume S; Gros C; Schwartz JC
    Life Sci; 1980 Jul; 27(3):245-52. PubMed ID: 6250001
    [No Abstract]   [Full Text] [Related]  

  • 15. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E; Hefti F; Wurtman RJ
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
    Schmauss C; Emrich HM
    Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioids and their receptors. Evidence for involvement in the postictal effects of electroconvulsive shock.
    Holaday JW; Tortella FC; Long JB; Belenky GL; Hitzemann RJ
    Ann N Y Acad Sci; 1986; 462():124-39. PubMed ID: 3010787
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphine-like peptides and dopaminergic pathways].
    Destee A
    LARC Med; 1981 Dec; 1(3):53-4, 57-8. PubMed ID: 6298510
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of endogenous opioids in the modulation of hypophyseal hormone secretion].
    De Marinis L; Mancini A; D'Amico C; Sambo P; Tofani A; La Brocca A; Barbarino A
    Minerva Med; 1990; 81(1-2):5-14. PubMed ID: 2156187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-induced withdrawal syndrome after administration of selective opioid agonists or after activation of the endogenous enkephalinergic system.
    Maldonado R; Waksman G; Feger J; Roques BP
    Prog Clin Biol Res; 1990; 328():531-4. PubMed ID: 2154817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.